Efficacy and Safety of Cilostazol for the Indication of CSPS

Completed

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Patient with an experience of cerebral infarction and having a purpose for prevention of recurrence of cerebral infarction.
- Age: more than 18 years of age

Exclusion Criteria

- Unqualified patients judged by study investigator(s)